文献速递MDS 与骨髓增殖性肿瘤

HIF-1α调控及血栓炎症基因失调或增加BCR::ABL1阴性MPN患者血栓风险

Dysregulation of HIF-1α-regulated and thromboinflammatory genes may contribute to thrombotic risk in patients with BCR::ABL1-negative myeloproliferative neoplasms.
PubMed 文献 · J Thromb Haemost · 2026-04-16

本研究分析了120例BCR::ABL1阴性骨髓增殖性肿瘤(MPN)患者(包括40例真性红细胞增多症、40例原发性血小板增多症和40例原发性骨髓纤维化)的HIF-1α调控及血栓炎症基因表达。研究发现不同MPN亚型基因表达模式不同,SLC2A1和SELP表达与血栓事件独立相关,NLRP3表达呈负相关。JAK2突变患者多数基因表达更高,而细胞减灭治疗对RNA表达无显著影响。

要点

  • SLC2A1和SELP表达与MPN患者血栓事件独立相关。
  • NLRP3表达与血栓事件呈负相关。
  • JAK2突变患者HIF-1α调控基因表达普遍更高。

核心结论

  • 亚型特异性的RNA表达模式可能反映不同MPN实体间血栓发生率的差异。
  • JAK2突变患者中较高的RNA表达支持JAK2信号与HIF相关通路之间的联系。

研究设计与样本

  • 研究纳入120例BCR::ABL1阴性MPN患者,其中真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化各40例。
  • 每个MPN亚型中50%患者有血栓史。
  • 采用定量逆转录聚合酶链反应测量RNA表达水平。

主要发现

  • 不同MPN亚型的RNA表达模式存在差异。
  • 原发性血小板增多症患者中F3表达更高,真性红细胞增多症和原发性骨髓纤维化患者中SLC2A1和SELP表达增加,且这些患者有血栓史。
  • 多数分析基因在JAK2突变患者中表达高于JAK2阴性患者,细胞减灭治疗对RNA表达无显著影响。

临床怎么用

  • SLC2A1和SELP表达可能作为MPN患者血栓风险的潜在生物标志物。
  • JAK2突变状态与HIF-1α调控基因表达相关,提示JAK2信号通路在血栓形成中的作用。

局限性

  • 需要进一步研究以阐明这些基因在MPN血栓形成中的作用及治疗潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoxia-inducible factor-1α (HIF-1α) regulates multiple pathways involved in metabolism, inflammation, and coagulation and may contribute to thrombotic complications in patients with BCR::ABL1-negative myeloproliferative neoplasms (MPN). OBJECTIVES: This study aimed to investigate the expression of selected HIF-1α-regulated and thromboinflammatory genes (SLC2A1, F3, SELP, VEGFA, SERPINE1, PROS1, NLRP3, and THBS1) and their association with thrombotic events, JAK2 mutation status, and cytoreductive therapy. METHODS: Data of 120 patients with MPN (40 with polycythemia vera, 40 with essential thrombocythemia, and 40 with primary myelofibrosis) and their blood samples were analyzed. In each MPN subtype, 50% of patients had a history of thrombosis. RNA expression levels were measured using quantitative reverse transcription polymerase chain reaction. RESULTS: RNA expression patterns differed across MPN subtypes. Higher F3 expression in essential thrombocythemia and increased SLC2A1 and SELP expression in polycythemia vera and primary myelofibrosis were observed in patients with thrombosis. In multivariable logistic regression, SLC2A1 (odds ratio [OR], 2.05; 95% CI, 1.20-3.49; P = .008) and SELP expression (OR, 1.79; 95% CI, 1.06-3.02; P = .03) remained independently associated with thrombotic events, whereas NLRP3 expression was inversely associated (OR, 0.58; 95% CI, 0.37-0.90; P = .02). Most analyzed genes were more highly expressed in patients with JAK2 mutation than in JAK2-negative patients. Cytoreductive therapy showed no significant impact on RNA expression. CONCLUSION: Subtype-specific RNA expression patterns may reflect differences in thrombotic incidence across MPN entities. Higher RNA expression in patients with JAK2 mutation supports a link between JAK2 signaling and HIF-related pathways. Further studies are warranted to clarify their role and therapeutic potential.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Morath O, Wolfrum T, Crodel C, et al. Dysregulation of HIF-1α-regulated and thromboinflammatory genes may contribute to thrombotic risk in patients with BCR::ABL1-negative myeloproliferative neoplasms. J Thromb Haemost. 2026. PMID: 42000137. doi:10.1016/j.jtha.2026.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。